Recent molecular-profiling studies have identified EF-Tu dysregulation as a potentially important event in cancer development and proposed it may serve as potential cancer biomarkers in mechanism of the mitochondrial changes in gastric tumor cell [14], but this postulation lacks clinical evidence. Here, TUFM is linked to cancer.